Spatially constrained tandem bromodomain inhibition bolsters sustained repression of BRD4 transcriptional activity for TNBC cell growth.
Ren, C., Zhang, G., Han, F., Fu, S., Cao, Y., Zhang, F., Zhang, Q., Meslamani, J., Xu, Y., Ji, D., Cao, L., Zhou, Q., Cheung, K.L., Sharma, R., Babault, N., Yi, Z., Zhang, W., Walsh, M.J., Zeng, L., Zhou, M.M.(2018) Proc Natl Acad Sci U S A 115: 7949-7954
- PubMed: 30012592 
- DOI: 10.1073/pnas.1720000115
- Primary Citation of Related Structures:  
6DJC, 6DNE - PubMed Abstract: 
The importance of BET protein BRD4 in gene transcription is well recognized through the study of chemical modulation of its characteristic tandem bromodomain (BrD) binding to lysine-acetylated histones and transcription factors. However, while monovalent inhibition of BRD4 by BET BrD inhibitors such as JQ1 blocks growth of hematopoietic cancers, it is much less effective generally in solid tumors ...